Ontology highlight
ABSTRACT:
SUBMITTER: Iams WT
PROVIDER: S-EPMC5002942 | biostudies-literature | 2015 Feb
REPOSITORIES: biostudies-literature
Iams Wade T WT Hames Megan L ML Tsai Judy P JP Dahlman Kimberly B KB Talbott Mahsa S MS Richards Kristy L KL Reddy Nishitha M NM
Experimental hematology 20141028 2
As the use of lenalidomide expands, the poorly understood phenomenon of lenalidomide-induced thyroid abnormalities will increase. In this study, we compared rates of therapy-induced hypothyroidism in 329 patients with diffuse large B-cell lymphoma (DLBCL) treated with conventional chemotherapy (DLBCL-c) or conventional chemotherapy plus lenalidomide (DLBCL-len). We measured serum levels of tumor necrosis factor α, interferon gamma, interleukin 6, interleukin 12, and interleukin 15 before and aft ...[more]